View on Pubmed.gov 23263379 | View on doi.org 10.1038/ncb2641
p53 mutations in cancer.
- The Beatson Institute for Cancer Research, Switchback Road, Bearsden, Glasgow, G61 1BD, UK.
Abstract
In the past fifteen years, it has become apparent that tumour-associated p53 mutations can provoke activities that are different to those resulting from simply loss of wild-type tumour-suppressing p53 function. Many of these mutant p53 proteins acquire oncogenic properties that enable them to promote invasion, metastasis, proliferation and cell survival. Here we highlight some of the emerging molecular mechanisms through which mutant p53 proteins can exert these oncogenic functions.
References
Mol Cell Biol. 2001 Mar;21(5):1874-87
Mol Cell Biol. 1996 Sep;16(9):4952-60
Cell Death Dis. 2012 Mar 15;3:e286
J Biol Chem. 1993 Apr 15;268(11):7923-8
Cited by 1543 citations (total)
Journal Article Review
Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review.
Electronic publication date November 19, 2014
Asfar S Azmi [...] Fazlul H Sarkar et al.
Trafficking of biological material across membranes is an evolutionary conserved mechanism and is part of any normal cell homeostasis. Such...
Journal Article Review
Battle against cancer: an everlasting saga of p53.
Electronic publication date July 17, 2015
Qian Hao [...] William C Cho et al.
Cancer is one of the most life-threatening diseases characterized by uncontrolled growth and spread of malignant cells. The tumor suppressor...
Conflict of interest statement
MeSH
- •
- •
- •
Specialties
- •
- •
- •
Substances
- •
- •
- •
- •
- •